Working… Menu

Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00314782
Recruitment Status : Completed
First Posted : April 17, 2006
Last Update Posted : March 12, 2013
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2008
Actual Study Completion Date : March 2009